Aug 06, 2019 · ArQule, Inc. ARQL is scheduled to report second-quarter 2019 results on Aug 7, before the market opens. The company’s earnings record has been mixed so far, having delivered a positive surprise in two of the last four quarters, missing expectations once while delivering in … ARQL Stock | Message Board | ArQule Inc. - Investors Hangout ARQL Stock Message Board for Investors. ArQule Inc. Stock Price, News and Company Updates. Message Board Total Posts: 72 Arqule Inc (ARQL-Q) Quote - The Globe and Mail
Apr 03, 2020 · Real time ArQule (ARQL) stock price quote, stock graph, news & analysis. Real time ArQule (ARQL) stock price quote, stock graph, news & analysis. The Motley Fool helps millions of people
ARQL Stock Quote - ArQule, Inc. Stock Price Today ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ArQule, Inc. (ARQL) Latest Stock News & Headlines - Yahoo ... Get the latest ArQule, Inc. (ARQL) stock news and headlines to help you in your trading and investing decisions. BSTC Stock Price | BioSpecifics Technologies Corp. Stock ... BSTC | Complete BioSpecifics Technologies Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ArQule: 3Q Earnings Snapshot | MarketScreener
Get the latest Zacks research report on KEM — FREE ETFs by nature are passive index-followers, so as long as the stock remains in the index, 1/6 - 11: 09 AM, Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM
Company profile for Arqule Inc (ARQL) including business summary, key statistics, ratios, sector. Coin Canadian Press Canadian Press Releases Cboe Options Hub Comtex Dividend Channel FreightWaves NewsBTC PR Newswire Schaeffers Zacks News. Dashboard. Tools. A stock's Profile page contains general information about the stock, such as ArQule - ARQL - Stock Price & News | The Motley Fool Apr 03, 2020 · Real time ArQule (ARQL) stock price quote, stock graph, news & analysis. Real time ArQule (ARQL) stock price quote, stock graph, news & analysis. The Motley Fool helps millions of people What Makes ArQule (ARQL) a New Buy Stock
ArQule, Inc. (ARQL) Latest Stock News & Headlines - Yahoo ...
Company Name: ArQule Inc., Stock Symbol: ARQL, Industry: Biotechs, Total Posts: 369, Last Post: 1/10/2020 10:39:59 AM ARQL -- Is Its Stock Price A Worthy Investment? Learn More. ARQL Stock Summary. ARQL's price/sales ratio is 505.69; that's higher than the P/S ratio of 99.33% of US stocks. Over the past twelve months, ARQL has reported earnings growth of 181.01%, putting it ahead of 93.26% of US stocks in our set. Stocks Page | StreetAuthority The Medicines Co.'s Carbavance Scores in Phase III Study - June 28, 2016 - 09:45 AM www.zacks.com; Forget Valeant, Invest in These Attractive Drug Stocks Instead - June 28, 2016 - 02:52 PM www.zacks.com; Valeant (VRX) Stock Down on Bleak View, Q1 Earnings Miss - June 08, 2016 - …
Arqule Inc (ARQL-Q) Quote - The Globe and Mail
Oct 15, 2019 · ArQule (ARQL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. ARQL ArQule, Inc. Stock Quote - FINVIZ.com